Kobayashi Pharmaceutical Co., Ltd. (FRA:KOY)

Market Cap	3.02B +34.4%
Revenue (ttm)	901.84M +3.7%
Net Income	8.75M -86.2%
EPS	0.12 -86.2%
Shares Out	n/a
PE Ratio	318.36
Forward PE	n/a
Dividend	0.58 (1.45%)
Ex-Dividend Date	Dec 29, 2026

Volume	n/a
Open	39.60
Previous Close	39.40
Day's Range	39.60 - 39.60
52-Week Range	27.40 - 40.40
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 10, 2026

About Kobayashi Pharmaceutical

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sh...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1886
• Employees: 3,731
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: KOY

Financial Performance

In 2025, Kobayashi Pharmaceutical's revenue was 165.74 billion, an increase of 0.09% compared to the previous year's 165.60 billion. Earnings were 3.66 billion, a decrease of -63.68%.

Financial numbers in JPY

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 24, 2026

Data Sources Report a data error